"Part of the HonorHealth Virginia G. Piper Cancer Care Network, the Shea cancer center has expert, compassionate physicians with special training in diagnosing and treating cancer and blood disorders."

During the past decade, Virginia G Piper Cancer Care-Del Camino conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 18 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia G Piper Cancer Care-Del Camino" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "Pfizer" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "Abbott" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia G Piper Cancer Care-Del Camino" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Virginia G Piper Cancer Care-Del Camino" are "Lung Cancer" (4 trials), "Breast Adenocarcinoma" (3 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Breast Neoplasms" (2 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Virginia G Piper Cancer Care-Del Camino" in a lesser frequency.

Most popular intervention types in "Virginia G Piper Cancer Care-Del Camino" are "Drug" (32 trials), "Other" (13 trials), "Radiation" (8 trials), "Biological" (6 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Quality-of-Life Assessment" (5 trials), "Anastrozole" (3 trials), "Cyclophosphamide" (3 trials) and "Doxorubicin Hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Virginia G Piper Cancer Care-Del Camino" are 31 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Virginia G Piper Cancer Care-Del Camino". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Virginia G Piper Cancer Care-Del Camino, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia G Piper Cancer Care-Del Camino, 9 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".